Primary |
Non-small Cell Lung Cancer |
20.4% |
Prophylaxis |
11.4% |
Pancreatic Carcinoma |
9.8% |
Breast Cancer Metastatic |
8.2% |
Hypertension |
5.9% |
Pain |
5.9% |
Nausea |
5.0% |
Constipation |
4.5% |
Breast Cancer |
3.6% |
Diffuse Large B-cell Lymphoma |
3.4% |
Pancreatic Carcinoma Non-resectable |
3.3% |
Transitional Cell Carcinoma |
2.9% |
Adenocarcinoma Pancreas |
2.8% |
Diabetes Mellitus |
2.4% |
Pancreatic Carcinoma Metastatic |
2.1% |
Bladder Cancer |
1.9% |
Bile Duct Cancer |
1.7% |
Premedication |
1.6% |
Prophylaxis Of Nausea And Vomiting |
1.6% |
Insomnia |
1.5% |
|
Pneumonia |
10.5% |
Thrombocytopenia |
8.7% |
Adverse Event |
8.1% |
Pulmonary Embolism |
7.6% |
Vomiting |
7.6% |
Pyrexia |
7.0% |
Death |
6.8% |
Hospitalisation |
5.2% |
Sepsis |
5.0% |
Neutropenia |
4.3% |
Renal Failure Acute |
3.9% |
Pleural Effusion |
3.7% |
Urinary Tract Infection |
3.5% |
Thrombotic Microangiopathy |
2.9% |
Deep Vein Thrombosis |
2.7% |
Weight Decreased |
2.7% |
Neutropenic Sepsis |
2.5% |
Platelet Count Decreased |
2.5% |
White Blood Cell Count Decreased |
2.5% |
Nausea |
2.3% |
|
Secondary |
Non-small Cell Lung Cancer |
29.8% |
Drug Use For Unknown Indication |
19.3% |
Hypertension |
6.3% |
Prophylaxis |
6.1% |
Pancreatic Carcinoma |
5.2% |
Prophylaxis Of Nausea And Vomiting |
4.6% |
Pain |
3.8% |
Constipation |
2.7% |
Pancreatic Carcinoma Metastatic |
2.4% |
Abdominal Pain |
2.2% |
Breast Cancer Metastatic |
2.2% |
Nausea |
2.1% |
Transitional Cell Carcinoma |
2.0% |
Breast Cancer |
1.7% |
Diffuse Large B-cell Lymphoma |
1.7% |
Chest Pain |
1.7% |
Diarrhoea |
1.7% |
Thrombosis Prophylaxis |
1.6% |
Bladder Cancer |
1.5% |
Anaemia |
1.4% |
|
Thrombocytopenia |
15.7% |
Pyrexia |
9.1% |
Neutropenia |
7.7% |
Vomiting |
7.7% |
Pulmonary Embolism |
7.5% |
Weight Decreased |
6.4% |
Sepsis |
4.6% |
Pleural Effusion |
4.4% |
Deep Vein Thrombosis |
4.0% |
Pneumonia |
4.0% |
Thrombosis |
4.0% |
Platelet Count Decreased |
3.5% |
Death |
3.3% |
Wound Infection |
3.3% |
White Blood Cell Count Decreased |
3.1% |
Renal Failure Acute |
2.9% |
Dyspnoea |
2.2% |
Epistaxis |
2.2% |
General Physical Health Deterioration |
2.2% |
Haemoptysis |
2.2% |
|
Concomitant |
Drug Use For Unknown Indication |
22.6% |
Product Used For Unknown Indication |
13.4% |
Breast Cancer |
9.5% |
Non-small Cell Lung Cancer |
7.9% |
Metastases To Bone |
7.0% |
Metastatic Renal Cell Carcinoma |
6.0% |
Breast Cancer Metastatic |
4.7% |
Pancreatic Carcinoma Metastatic |
4.3% |
Chemotherapy |
3.0% |
Adenocarcinoma Pancreas |
2.9% |
Ovarian Cancer |
2.4% |
Pancreatic Carcinoma |
2.2% |
Pleural Mesothelioma Malignant |
2.2% |
Nausea |
2.0% |
Anxiety |
1.7% |
Hiv Infection |
1.7% |
Lung Adenocarcinoma Metastatic |
1.7% |
Pain |
1.7% |
Pain In Jaw |
1.6% |
Anaemia Of Malignant Disease |
1.4% |
|
Stomatitis |
7.8% |
Vomiting |
7.8% |
Wound Infection Staphylococcal |
7.8% |
Thrombocytopenia |
7.0% |
Pneumonia |
6.2% |
Pyrexia |
6.2% |
Weight Decreased |
5.4% |
Rash |
4.7% |
Tachycardia |
4.7% |
Tooth Extraction |
4.7% |
Upper Respiratory Tract Infection |
4.7% |
Vision Blurred |
4.7% |
White Blood Cell Count Decreased |
4.7% |
X-ray Abnormal |
4.7% |
Death |
3.9% |
Pulmonary Embolism |
3.9% |
Septic Shock |
3.1% |
Sudden Death |
3.1% |
Wound Drainage |
3.1% |
Febrile Neutropenia |
2.3% |
|